Gilteritinib-induced upregulation of S100A9 is mediated through BCL6 in Acute Myeloid Leukemia
Ontology highlight
ABSTRACT: Gilteritinib-induced upregulation of S100A9 is mediated through BCL6 in Acute Myeloid Leukemia
PROVIDER: PRJNA743665 | ENA |
REPOSITORIES: ENA
ACCESS DATA